A Brief Video Intervention to Improve Patient Outcomes Following Radioiodine Treatment
NCT07405320 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2026-02-12
Summary
This study will test the impact of a short video intervention for people who are receiving radioiodine treatment for thyroid conditions (such as hyperthyroidism or thyroid cancer). After their single-dose treatment, patients need to follow safety instructions to protect others and manage side effects during recovery. Some people find these instructions hard to remember, and side effects (or anticipation of side effects) can feel worrying or disruptive. The video aims to present the treatment information in a more accessible patient-friendly way, so that patients feel less distressed, find their side effects easier to cope with, and better engage with safety precautions. All patients will first have a pre-treatment consultation with their doctor and receive the standard treatment information currently provided. Before this consultation patients will be randomly assigned to view one of two videos. The control group will see a neutral video that details standard health information that is not specific to radioiodine, while the intervention group will see a video that explains side effects, safety requirements and recovery period in a more adaptive way. Comparing these two groups will allow us to assess whether this new approach improves coping, reduces distress, and enhances adherence to safety instructions in the post-dose recovery phase of radioiodine treatment.
Conditions
- Thyroid Cancer
- Hyperthyroidism
- Radioiodine Treatment
Interventions
- BEHAVIORAL
-
Intervention Video
Participants will view a brief prerecorded video (approximately 4 minutes) online, delivered through Qualtrics, following completion of the baseline questionnaire. The intervention video will present information on radioiodine treatment recovery, managing treatment side effects, and radiation safety requirements. The video will be delivered online prior to the participant's radioiodine treatment, using patient-friendly language and supportive framing.
- BEHAVIORAL
-
Control Video
Participants will view a brief prerecorded neutral video (approximately 4 minutes) online, being delivered through Qualtrics following the baseline questionnaire. The control video will present general health information unrelated to radioiodine treatment (e.g., healthy lifestyle topics such as nutrition and stress management). The video will be delivered online prior to the participant's radioiodine treatment, and will match the intervention video in duration, format, and presenter.
Sponsors & Collaborators
-
University of Auckland, New Zealand
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-12
- Primary Completion
- 2026-07-06
- Completion
- 2026-07-06
More Related Trials
-
Clinical Study of Biokinetic Model of Iodine-131 in Total(Near) Thyroidectomy Patients.
NCT03349294 ·Status: COMPLETED
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT05733013 ·Status: RECRUITING
-
Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis
NCT03720210 ·Status: TERMINATED ·Phase: NA
-
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
NCT00004062 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism
NCT01039818 ·Status: COMPLETED ·Phase: PHASE3
-
Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer
NCT01083550 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Block-replacement Therapy During Radioiodine Therapy
NCT00150124 ·Status: COMPLETED ·Phase: PHASE4
-
Iodine I 131 in Treating Patients With Thyroid Cancer
NCT00416949 ·Status: TERMINATED ·Phase: NA
-
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
NCT00970359 ·Status: COMPLETED ·Phase: NA
-
Hyperthyroid Follow-Up Study
NCT02989103 ·Status: COMPLETED
-
Iodine Uptake After a Low Iodine Diet
NCT05599139 ·Status: RECRUITING ·Phase: NA
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
NCT06558981 ·Status: RECRUITING ·Phase: PHASE3
-
Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?
NCT00151723 ·Status: UNKNOWN ·Phase: NA
-
Early Levothyroxine Post Radioactive Iodine
NCT01950260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Quality of Life After Interventional Thyroid Treatment
NCT03880578 ·Status: COMPLETED
-
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
NCT06980103 ·Status: RECRUITING ·Phase: NA
-
Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer
NCT04892303 ·Status: RECRUITING ·Phase: PHASE1
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)
NCT03606824 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
NCT02706743 ·Status: UNKNOWN
-
Treatment of M.Graves With Radioactive Iodine: Follow-up Study
NCT00525122 ·Status: UNKNOWN
-
the Microbiota Are Associated With Iodine-131 Therapy and Hypothyroidism
NCT03574051 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
NCT00360074 ·Status: COMPLETED ·Phase: PHASE4
-
Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4
-
Interventional Study to Improve Medication Adherence Using Patient Decision Aid
NCT06205303 ·Status: COMPLETED ·Phase: NA